Curr Vasc Pharmacol 2020 Jan 29
Cardiovascular disease in the Systemic Vasculitides.
Soulaidopoulos S, Madenidou AV, Daoussis D, Melissaropoulos K, Mavrogeni S, Kitas G, Dimitroulas T
The vasculitides are a heterogeneous group of disorders, characterized by inflammatory cell infiltration and necrosis of blood vessels that cause vasc ...
Read More
Source: PubMed
Mod Rheumatol 2020 Jan 31
Efficacy and safety of tocilizumab in treatment of Takayasu arteritis: A systematic review of randomized controlled trials.
Singh A, Danda D, Hussain S, Najmi AK, Mathew A, Goel R, Lakhan SE, Tajudheen B, Antony B
Background: Takayasu arteritis (TAK) is a chronic immune vasculitis in which Interleukin-6 (IL-6) receptors play a key role in pathogenesis. Tocilizum ...
Read More
Source: PubMed
J Assoc Physicians India
Pregnency with Takayasu Arteritis.
T K KR
Read More
Source: PubMed
Medicine (Baltimore)
Effectiveness of Tocilizumab in juvenile patients with refractory Takayasu arteritis: Two case reports.
Asano T, Sato S, Temmoku J, Fujita Y, Furuya MY, Matsuoka N, Kobayashi H, Suzuki E, Watanabe H, Migita K
Takayasu arteritis (TA) is a systemic large-vessel vasculitis which can be accompanied by the symptoms associated with vascular stenosis. ...
Read More
Source: PubMed
Acta Clin Croat
Aggressive progression of Takayasu's arteritis in infancy: a case report.
Pavic R, Blažekovic R, Divkovic D, Marjanovic K, Sipl M
Takayasu's arteritis (TA) affects the aorta and its branches. Immunosuppressants are the usual course of therapy, while surgery has been used in acute ...
Read More
Source: PubMed
